Precise gating of voltage-gated ion channels is a crucial component in producing proper neuronal, cardiac, and skeletal muscle action potential (AP) waveform and duration.
The orchestrated activities of voltage-gated potassium (K v ) channels are responsible for the repolarizing phases of the AP, with regulated or aberrant changes in K v channel activity often modifying AP repolarization (1) .
Such AP remodeling is observed throughout physiological processes including development, aging, and synaptic plasticity(2-4). AP remodeling also may produce pathological consequences such as Long QT Syndrome, deafness, and epilepsy (5) (6) (7) (8) .
Ion channels undergo significant posttranslational modification, including glycosylation, which comprises upwards of 30% of the total channel mass (9) . Ion channel activity can be modulated by glycosylation through isoform-specific mechanisms (10) (11) (12) (13) (14) (15) (16) (17) . Such changes in ion channel activity would lead to altered AP waveforms, and thereby modulate excitability.
Glycans are attached to channel proteins through N-and O-linkages and generally are terminated by negatively charged sialic acids (SA) (18;19) . Several studies detailed the isoformspecific effects of N-glycans on K v channel (13-17;20) and voltage-gated Na + (Na v ) channel function (10) (11) (12) . Negatively charged sialic acids (at physiological pH) are typically the terminal residues of glycoprotein glycan structures, and were shown to impact gating of various voltagegated ion channels differentially (10-17;20;21) . Such studies were possible because an external consensus site for N-glycosylation has been identified.
On the other hand, little is known about the role of O-glycosylation in voltage-gated ion channel activity. The enzymes regulating Oglycosylation are complex, and O-glycosylation does not have a recognized consensus sequence (22) .
The most prevalent form of extracellular O-glycosylation is the mucin-type, in which an N-acetylgalactosamine (GalNAc) is bound to hydroxyl groups of serine or threonine side chains (19;23) .
All previous efforts to study the impact of glycosylation on K v channel function concentrated on determining effects of N-glycosylation or generic sialylation (13-17;20;21) .
To our knowledge, no one has reported a role for external O-glycans in K v channel function. K v 4.2 and K v 4.3 are members of the Shal subfamily of K v channels and are rapidly activating and inactivating (A-type) channels (1) . The putative external sequences of K v 4.2 and K v 4.3 do not contain potential N-glycosylation sites; therefore, neither isoform can be N-glycosylated. K v 2.1 is a delayed rectifier with one N-glycosylation site located on the S3-S4 linker. Based on recent structural models, this site may be inaccessible to the glycosylation machinery of the cell(24;25); consistently, brain K v 2.1 was shown to contain no N-glycans (26) .
In this study, we investigated whether and how sialic acids modulate gating of K v 2.1, K v 4.2, and K v 4.3, and probed for the presence of sialylated O-glycans using two independent methods -Click chemistry and glycosidase treatment. The data show for the first time that K v channel isoforms are uniquely modulated by sialic acid residues attached to the channel through Olinkages.
Experimental Procedures
CHO Cell Culture and Transfection -Pro5 and Lec2 cells were grown in minimal medium and transfected with channel cDNA as previously described (13;27) . Briefly, the cells were plated at 25-50% confluence on 35 mm dishes 24 hours prior to transfection with 1ml Opti-MEM (Invitrogen) containing 8 μl of lipofectamine (Invitrogen), 0.25 μg of eGFP, and 2.5 μg of channel cDNA (rat) and incubated at 37°C in a 5% CO 2 humidified incubator.
24 hours posttransfection, the media was replaced with growth medium, consisting of alpha-minimum essential medium (αMEM; Invitrogen) with (Pro5) and without (Lec2) ribo-and deoxyribonucleosides supplemented with 10% fetal bovine serum (FBS; Hyclone) and penicillin/streptomycin (Mediatech). Cells were incubated at 37°C for another 48 hours prior to commencing electrophysiological recordings.
Whole Cell Recordings in CHO Cells
The Pro5/Lec2 expression system previously was used successfully to determine the effects of sialic acids on channel gating (10-17;21) . Whole cell current recordings were performed using pulse protocols, solutions, whole cell patch clamp techniques, and data analyses as described previously (13;14) .
All experiments were conducted at room temperature, ~22ºC. Drummond capillary tubes were pulled into electrodes with a resistance of 1-2 MΩ using a Model P-97 Sutter electrode puller.
Series resistance was compensated 95-98%.
The extracellular solution was (mM): 65 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 155 sucrose, 5 glucose, 10 Hepes (pH 7.3), while the intracellular solution used was (mM): 70 KCl, 65 KF, 5 NaCl, 1 MgCl 2 , 10 EGTA, 5 glucose, 10 Hepes (pH 7.3). The extracellular low divalent cation solution was similar to the ECF listed above, with the exception of a 0.2 mM concentration of CaCl 2 and a 0.1 mM concentration of MgCl 2 . To ensure complete dialysis of the intracellular solution, data were collected at least 10 minutes after attaining whole cell configuration. Pulse Protocols -The steady-state and kinetic gating parameters were examined through the use of standard pulse protocols and solutions previously described by our lab (13;14) .
Conductance-voltage (G-V) relationshipCells were held at -120 mV, stepped to more depolarized potentials (-100 mV to +40 mV in 10 mV increments) for 100 ms (K v 4.2 and K v 4.3) and 200 ms (K v 2.1), and returned to the holding potential. Consecutive pulses were stepped every 1.5 s and the data were leak subtracted using the P/4 method, stepping negatively from the holding potential. Steady-state whole cell conductance values (G) were determined using Ohm's Law (G = I/(V -E k )), where I is the measured peak current at a test potential, V. E k is the predicted K + Nernst equilibrium potential (+84 mV) for the set of intraand extracellular solutions used. The maximum conductance generated by each cell was used to normalize the data for each cell to its maximum conductance by fitting the data to a single Boltzmann distribution (equation 1, solving for maximal conductance). These single Boltzmann distributions were used to determine the average V a ± SEM and K a ± SEM values listed in Table 1 . The normalized data were averaged with those from the other cells and the resulting average G-V curve was fit via least squares using the following Boltzmann relationship:
where V is the membrane potential, V a is the voltage of half-activation, and K a is the slope factor.
Steady-State Inactivation Curves (h inf ) -To determine the steady-state channel availability for the fast inactivating K v 4.2 and K v 4.3 isoforms, cells were prepulsed from -120 mV to +20 mV (10 mV increments) for 1000 ms, then stepped to +60 mV for 100 ms, and returned to the holding potential (-120 mV). To discern the effects of glycosylation on K v 2.1 steady-state slow inactivation, cells were pre-pulsed from -110 mV to +40 mV (10 mV increments) for 5 s, stepped to +30 mV for 500 ms, and returned to the holding potential (-120 mV) for 15 s, similar to that described previously (28;29) .
For both protocols, the maximum current generated by each cell was used to normalize the data for each cell to its maximum current by fitting the data to a single Boltzmann distribution (equation 2, solving for maximal current), from which the mean V i ± SEM and K i ± SEM values listed in Table 1 were determined.
Fraction of maximal current
where V is the membrane potential, V i is the voltage of half-inactivation, and K i is the slope factor.
Recovery from Fast Inactivation (for K v 4.2 and K v 4.3) -Cells were held at -120 mV and stepped to +60 mV for 100 ms and then stepped to a -140 mV recovery potential for various time intervals (10 -200 ms in 10 ms increments). The membrane potential then was stepped to +60 mV for 100 ms. Peak currents measured during the +60 mV depolarizations were compared and the fractional peak current that remained during the second depolarization was plotted as a function of the recovery pulse duration, representative of the fraction of channels recovered from inactivation during the recovery interval. K v 2.1 Channel Mutagenesis -K v 2.1 vector construction and mutagenesis were performed similar to that previously described (13;14) . A K v 2.1 plasmid encoding the 857 amino acid form of the channel protein was utilized throughout this study. The asparagine residue (N) located at site 283 was mutated to glutamine (Q). Generally, the cDNA containing the α-subunit open reading frame was inserted into pcDNA3.1. Using the Stratagene Quickchange IIXL site-directed mutagenesis kit, mutagenesis was completed and the constructs were sequenced. Whole Cell Homogenization -Cells were rinsed with cold PBS and incubated for 5 minutes in ice cold sodium pyrophosphate buffer with protease inhibitors as described previously (13;14) . Cells were then homogenized using manual tissue grinders. The homogenates were centrifuged for 10 minutes at 1000 x g in a Beckman bench-top centrifuge. The supernatant was centrifuged in a Beckman ultracentrifuge for one hour at 100,000 x g after which, the pellet was resuspended in an appropriate volume of sodium pyrophosphate buffer containing protease inhibitors. The lysates were then stored at -80ºC. Protein levels were determined using the Pierce BCA Protein Assay kit. Deglycosylation of homogenates -Several sets of glycosidases were used to remove N-and Oglycans and sialic acids. For experiments shown in Fig. 3 , two different N-glycanase enzymes were used -PNGase-F (5 U/10 μg protein, Sigma) and N-glycanase (5 mU/10 μg protein for K v 1.4; 5 mU/2 μg protein for K v 2.1, Glyko). Lysates were treated for 3 hours at 37°C. For removal of sialic acids and O-glycans, as done in Fig. 6 and Table  2 , lysates were treated for 3 hours at 37°C with at least 1 mU/10 μg protein O-glycanase and with at least 4 mU/10 μg protein Sialidase A (both from Glyko). Sialic acids must be removed from Oglycans in order for O-glycanase to work properly, and therefore the O-glycanase treated samples 4 were treated with Sialidase A for 1.5 hours at 37°C prior to O-glycanase treatment. Immunoblots -Immunoblot analysis was performed as described previously (10;13;14) . Briefly, cell homogenates (2-25 µg/lane) were combined with one volume of 2x sample buffer (10% glycerol, 5% 2-mercaptoethanol, 3% sodium dodecyl sulfate, and 12.5% upper Tris buffer) and denatured for 3 minutes in boiling water. Samples were then run on a 6.0-6.5% SDS-PAGE gel for 90 minutes at 75-110 mV and transferred onto a nitrocellulose membrane using a semi-dry transfer cell (BioRad). Monoclonal anti-K v 2.1, anti-K v 4.2, and anti-K v 4.3 antibodies (1:500-1000 dilution; NeuroMab) were utilized to detect K v 2.1, K v 4.2, and K v 4.3, respectively. After incubation with primary antibody, the blot was treated with a goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1:25,000 dilution; Jackson) and visualized using an enhanced chemiluminescence kit (Pierce).
Click-iT Glycoprotein Labeling and DetectionClick-iT Glycoprotein Metabolic Labeling
Reagents and Detection Kits were utilized for these reactions (Invitrogen, Molecular Probes). Pro5 cells were transfected with each of the K v channel isoforms and with the expression vector pcDNA3.1 alone, as described previously (10;11;13;14) . Eight hours post-transfection, the cells were re-plated in the presence of the tetraacetylated azido sugar of interest at a concentration of 2.5 million cells/100mm dish and incubated for 48-72 hours at 37°C. Tetraacetylated azido-modified sugars were incorporated into protein glycan structures through the permissive characteristics of oligosaccharide synthesis.
N-azidoacetylgalactosamine (Ac 4 GalNAz) was metabolically integrated into Oglycosylation structures through the Nacetylgalactosamine (GalNAc) salvage pathway. N-azidoacetylmannosamine (Ac 4 ManNAz) was utilized to incorporate a modified sugar into the sialic acid biosynthesis pathway. The cells were then harvested and lysed.
Azide-modified glycoprotein samples were labeled with a biotinalkyne and precipitated(30;31). The precipitated sample was resolubilized and incubated on streptavidin-bound Dynabeads (Invitrogen). Because of the strong interaction between streptavidin and biotin, this step allowed for the isolation of only those proteins with the modified sugar incorporated into their glycosylation structures. Immunoblot analysis was performed on the samples and channel-specific antibodies were used to probe for channels of interest (1:100-1000 dilution) as described above. Three different controls were used: 1) Samples from the first wash following incubation of the biotinylated-modified glycoprotein samples with streptavidin-bound beads were run on the gel. Little to no signal was detected in the wash samples upon incubation with channel-specific antibody, indicating that biotinlabeled K v channel proteins bound to streptavidin specifically and with apparent high efficiency.
2) The pcDNA3.1 transfected Pro5 cell line was treated identically to the K v channel transfectants. No bands were observed for any of the pcDNA3.1-transfected blots. 3) Cells were not incubated with the azido-modified sugars, but all other steps of the process were completed. As shown in Figure 6 , no bands were observed. The three controls combined with the positive bands observed in the experimental samples indicate that azido-modified sugars incorporated specifically into each of the three K v channel isoforms. The experiment was repeated at least 5 times for each K v channel isoform, with nearly identical results. Data Analysis -Electrophysiological data were analyzed using Pulse/PulseFit (HEKA) and Sigma Plot (SSPS Inc.) as described previously (10-14;32;33) .
Glycosidase gel shift data were analyzed using the Quantity One 1-D gel analysis software (Bio-Rad), as described previously (32) . (26) . One previous report showed that the cardiac transient outward current (I to ), which is generated in the mouse primarily by the activity of K v 4.2 and K v 4.3, was altered under conditions of reduced sialylation (21) . To question whether sialic acids attached to channel O-glycans modulate the function of K v channels that are not N-glycosylated, these three isoforms were expressed in two Chinese Hamster Ovary (CHO) cell lines that differentially sialylate glycoproteins. Pro5 cells are fully sialylating (+SA), while Lec2 cells are essentially non-sialylating (-SA) due to a deficiency in the CMP-sialic acid transporter (34) . This deficiency serves as a model for a form of Congenital Disorders of Glycosylation (CDG), CDG type IIf (35) . The Pro5/Lec2 cell system has been used by several investigators, including our laboratory, to question how sialic acids modulate ion channel gating (10-16;21) . Channel sialylation was reduced through a second independent mechanism -enzymatic desialylation through sialidase treatment. Enzymatic desialylation of Lec2 cells was used as a negative control. As shown previously by our lab and others, channels expressed in Lec2 cell lines (± sialidase treatment) and fully glycosylated channels treated with sialidase showed nearly identical gating characteristics (15;21;36;37) .
RESULTS

Several
K v channel Oglycosylation and sialylation were confirmed through two independent methods, O-glycosidase gel shift analysis and Click chemistry. Kv2.1 is not likely N-glycosylated. K v 2.1 is a delayed rectifier channel that produces a slowly inactivating current and contains one Nglycosylation site located on the S3-S4 linker(1). Previously, K v 2.1 was shown to not be Nglycosylated in the brain (26) or in COS cells (38) . To determine whether K v 2.1 at site 283N is Nglycosylated in CHO cells, a K v 2.1 Nglycosylation mutant (K v 2.1 N283Q ) was generated by mutating the asparagine residue (N) that initiates the potential N-glycosylation consensus sequence to a glutamine (Q). In addition, fully glycosylated K v 2.1 lysates were treated with two N-glycanases, PNGase-F and N-glycanase. These enzymes were used to remove the full N-glycan structures, as previously performed by our lab (13;14;33) . Immunoblot analyses showed that the electrophoretic mobilities (M r ) of untreated K v 2.1, K v 2.1 N283Q , and K v 2.1 treated with each Nglycanase were nearly identical, consistent with K v 2.1 having no N-glycans attached to the channel protein as expressed in CHO cells. Conversely, note the large shift in M r of K v 1.4 following PNGase-F and N-glycanase treatment; this was used as an example of the efficacy of removing channel N-glycans by enzymatic treatment, as K v 1.4 is a K v channel isoform previously shown to be N-glycosylated(14;26).
There are several possible explanations for the lack of glycosylation of the potential K v 2.1 N-glycosylation site. A likely possibility is that the N-glycosylation site, located on the S3-S4 linker, is not accessible to the glycosylation machinery (as suggested by the K v channel crystal structures(24;25)). Thus, addition of N-glycans would be prevented.
Sialic acids modulate K v 2.1 activation. To determine whether sialic acids impact K v 2.1 channel function, channel gating was studied under conditions of full and reduced sialylation. Under all three conditions of reduced sialylation, K v 2.1 activated at more depolarized potentials than the fully sialylated channel (Fig. 4A, Table 1 ). The G-V relationship and V a for the less sialylated K v 2.1 were shifted linearly by a significant depolarizing ~9 mV compared to fully sialylated channels. The data indicate that a stronger depolarization is required to activate K v 2.1 in the absence of sialic acids (Fig. 4, Table 2 ).
Sialic acids do not affect K v 2.1 slow inactivation. K v 2.1 does not undergo fast N-type inactivation, but does slowly inactivate. Thus, we measured the voltage-dependence of steady-state slow inactivation for K v 2.1 in Pro5 and Lec2 cells (Fig. 4B, Table 1 ). There was no significant difference measured in the steady-state inactivation curves or in the voltages of halfinactivation (V i ) under conditions of full and reduced sialylation. These data are consistent with that previously reported by our lab for K v 1.5 (14) . However, K v 2.1 steady-state inactivation does not show U-type inactivation, as reported previously by some labs for K v 2.1 expressed in Xenopus oocytes and HEK cells (39) (40) (41) (42) . Instead, the steady-state inactivation curves shown in Fig. 4B are similar to that reported by others in recent studies using comparable pulse protocols to measure K v 2.1 inactivation in other mammalian cells (29;43-47) .
Electrostatic mechanisms account for the effect of sialic acids on gating of three K v channel isoforms. Sialic acids are negatively charged residues at physiological pH that may contribute to the external negative surface potential, impacting voltage-dependent channel gating. With increased negative surface charge, the channel would activate at less depolarized potentials. That is, if sialic acids contribute to a negative surface potential, then channels with greater levels of sialic acids would be predicted to activate at less depolarized potentials than channels with reduced levels of sialylation. The presence of external divalent cations will screen this surface potential and limit the impact of the negatively charged sialic acid residues on channel gating(48;49). Here, the V a for K v 2.1, K v 4.2, and K v 4.3 as expressed under conditions of full and reduced sialylation were measured and compared at two different divalent cation concentrations. The data show the V a for each isoform as expressed under conditions of full sialylation was significantly more sensitive to changes in external divalent concentrations than were the V a for the isoforms expressed in Lec2 cells (Fig. 5) . These data are consistent with an electrostatic mechanism by which sialic acids alter the activation of K v 4. (Fig. 3) . Thus, the data suggest it is likely that sialic acids attached to Oglycans are responsible for the observed effects on channel gating.
To question whether K v 2.1, K v 4.2, and K v 4.3 are O-glycosylated and sialylated, we employed previously used methods of glycosidase gel shift analysis(10;14;33;50). Figure 6 shows typical blots for the three isoforms under control, Oglycosidase, and sialidase-treated conditions. Following repeated experiments (n=4-8 for each isoform, see Table 2 ), the data show a significant shift in O-glycosidase treated samples compared to untreated control and sialidase treated lysates, suggesting that each isoform is O-glycosylated and sialylated.
While the gel shifts observed following Oglycosidase and sialidase treatments are significant, they are small. This is not surprising given the relatively small size of O-glycan structures. That is, O-glycans typically consist of only a few sugar residues; one would expect to observe only a small shift in M r following removal of the O-glycan structure.
In addition, the complete removal of glycans using glycosidase (particularly O-glycanase) treatment is difficult. Thus, we employed a second independent method to question whether the K v channel isoforms were O-glycosylated and sialylated using Cu (I Fig. 7) . As described in the methods, the three controls, along with the positive banding data shown in Fig. 7 , indicate that the O-glycosylation and sialic acid specific azido-modified sugar residues incorporated into all three K v channel isoforms. This set of experiments was repeated at least six times per isoform, with similar results. These data corroborate the glycosidase gel shift analysis shown in Fig. 6 and suggest that each K v channel isoform tested is O-glycosylated and sialylated. Figures  1 and 4 show that a reduction in sialic acids causes a significant and depolarizing shift in the G-V relationship that is unique for each isoform. Further, the data indicate that sialic acids modulate the activity of each isoform through apparent electrostatic mechanisms. Based on the surface potential theory, negative charges on the outer surface of the membrane (e.g., sialic acids) generate a surface potential. A depolarization would be sensed by the channel gating mechanism with increases in external negative surface charge, and thus, channel activation would require a smaller depolarization (48;49) . Extracellular divalent cations should act to limit the effects of negatively charged sialic acid residues, effectively reducing the negative surface potential, and cause a shift in the V a to more depolarized potentials. The greater the surface potential, the larger the predicted shift in the V a with changes in extracellular divalent cation concentration because there are effectively more negative surface charges that can be screened by divalent cations. We found that the V a for channels expressed in the fully sialylating Pro5 cells were more sensitive to changes in extracellular divalent cation concentration than channels expressed in the Lec2 cells (-SA, Fig. 6 ). Thus, sialic acids modulate K v 2.1, K v 4.2, and K v 4.3 activation through apparent electrostatic mechanisms (48;49). Further, changes in sialylation shifted the G-V curve for each isoform nearly linearly; there was no significant difference in the Boltzmann slope factors (K a values) with changes in sialylation ( Figs. 1 & 4 ; Table 1 ). This suggests that changes in K v 2.1, K v 4.2, and K v 4.3 sialylation primarily alter the negative surface potential, with little to no effect on the stability of channels among functional states. These data are consistent with our recent findings for K v 1.5 (14) .
DISCUSSION
Channel availability for each isoform and recovery from fast inactivation for K v 4.2 and K v 4.3 were not altered by channel sialylation levels (Fig. 2, Table 1 ). Some recent studies showed that the surface charge effects of sialic acids on channel voltage-dependent gating typically and similarly affected all voltagedependent gating mechanisms (13;16) . That is, a shift in fast inactivation voltage similar to the observed linear shift in channel activation voltage is consistent with an electrostatic mechanism. In this study, we show that sialic acids shift only the G-V relationship for each isoform, with no effect on inactivation or recovery from fast inactivation (for K v 4.2 and K v 4.3). The data also indicate that sialic acids modulate activation voltage by contributing to the negative surface potential (Fig.  5) . Together, these data suggest that sialic acids affect channel gating through electrostatic mechanisms, but do not confer a uniform effect on all voltage-dependent gating mechanisms. One likely explanation is that sialic acids impose a variable effect on the electric field sensed by the channel gating mechanisms, such that only activation is affected. As reviewed by Hille (1), contribution of local surface potentials to voltagedependent gating may vary with each gating step and between forward and reverse gating kinetics. Our recent work on K v 1.5 showed a similar phenomenon (14) . Thus, an inhomogeneous effect of sialic acids on the local electric field could account for the variable effect of reduced sialylation among voltage-dependent gating characteristics such as channel activation, inactivation, and recovery from fast inactivation with changes in channel sialylation.
A single previous report indicated that sialic acids impact gating of cardiac I to and K v 4.3 (21) . Specifically, sialic acids were shown to modulate I to of primarily isolated adult ventricular myocytes. I to in the mouse is comprised largely of K v 4.2 and K v 4.3, neither of which can be N-glycosylated. Thus, this previous report strongly suggests that K v 4.3 and, likely, K v 4.2 are sialylated in vivo. However, the study did not determine whether the channel sialic acids were attached through N-or O-linkages. Our data are in general agreement with the previous report with respect to K v 4.3 gating in vitro; K v 4.3 channel activation voltage was shifted to depolarized potentials under conditions of reduced sialylation. The preceding report indicated a small, but significant, shift in channel inactivation voltage that we did not observe. There are several possible reasons for the relatively minor differences between our data and that previously described, including the use of different external and internal solutions to record K + currents. It was shown in the previous study that sialolipids contribute at most 3-4 mV to K v 4.3 channel gating. We measure a much larger sialic acid-dependent shift for K v 4.3 (~ 8 mV) and K v 2.1 gating (~9 mV), with an even greater shift observed for K v 4.2 gating (~16 mV). Together, these data indicate that most of the effect of sialic acids on gating of these three K v channel isoforms is caused by channel sialic acids attached to Oglycans.
While Further studies are required to determine how specific changes in the number and/or location of O-linked sialic acids impact K v 4 channel activation.
In general, N-and O-glycan structures are very diverse -even the core structures for N-and O-glycans are distinct from one another. Nglycans tend to be significantly larger and more branched than O-glycans, which are typically a few residues in length. The smaller (shorter) Oglycans would likely be more rigid structures located closer to the membrane surface. Sialic acids typically are attached to the terminus of both N-and O-glycans, which would likely place sialic acids attached to N-and O-glycans at different locations relative to the membrane, channel, and electric field. Thus, the sialic acids attached to the end of the shorter O-glycan structures likely affect channel gating differently than sialic acid residues terminally located on a much longer and branched N-glycan. Some of this becomes apparent when comparing the data showing changes in K v channel gating with reduced glycosylation and sialylation. A spectrum of effects were observed, ranging from no measurable effect to ~ 20 mV shifts on activation only (14) , to large effects on several (or all) voltage-dependent gating parameters (13;15-17) , to apparent changes in stability of the channel among functional states(13;16). These variable effects alone suggest that the location (in three dimensions) of the sialic acids relative to the channel gating mechanism likely contributes to the measured impact of sialic acids on channel gating.
Here, the impact of O-linked sialic acids on K v gating is variable in magnitude for two K v 4 isoforms (K v 4.2 versus K v 4.3), but the mechanism appears to be similar. However, the magnitude and mechanism by which N-linked sialic acids modulate orthologous K v channel gating appears to be strictly isoform-specific, as we and others have published previously (13) (14) (15) (16) (17) . Together, there is abundant evidence that sialic acids attached to N-and O-glycans can, and do, modulate K v channel isoforms through isoform specific mechanisms -in the magnitude of an electrostatic effect, the impact of the electrostatic effect on gating, and/or on the contribution to channel state stability.
None of the K v channel isoforms investigated in this study is N-glycosylated. Our data indicate that all three isoforms are O-glycosylated and sialylated (Figs. 6, 7) . Here, we show that K v channel sialic acids attached to O-glycans modulate channel gating through isoform-specific mechanisms. No previous reports linked K v channel extracellular O-glycosylation to channel gating. Thus, the data presented in this study reflect a novel finding that K v channel gating can be modulated by channel sialic acids attached to O-glycans through isoform-specific mechanisms.
Physiological and pathophysiological implications. Normal gating of voltage-gated ion channels is essential for proper excitable cell function. Changes in ion channel function can lead to disorders such as Long-QT Syndrome and epilepsy(5;6;54). Because channel glycosylation and sialylation modulate K v channel gating through isoform-specific mechanisms, aberrant changes in K v channel isoform expression, distribution, and glycosylation may play a role in the pathogenesis of such disorders.
Aberrant sialylation is involved in Congenital Disorders of Glycosylation (CDGs). CDGs are autosomal dominant disorders in which afflicted individuals present with severe developmental delay (55) (56) (57) (58) (59) While the exact mutated glycosylation structure varies among CDGs, all CDG patients suffer from reduced protein sialylation. It is intriguing to consider whether the patient's reduced glycoprotein sialylation may be responsible for changes in ion channel activity and potentially contribute to symptoms.
Chagas' disease afflicts ~18 million people and is caused following infection by the parasite Trypanasoma Cruzi (T. Cruzi). Mortality rate is ~30% of the total cases, with nearly all of these patients experiencing heart failure preceded by ventricular tachycardia (61) (62) (63) (64) (65) . Interestingly, T. Cruzi release a neuraminidase shown to reduce the level of cardiomyocyte sialylation (66) . Individuals suffering from Chagas' disease experience arrhythmias and conduction anomalies more frequently than those with non-chagasic dilated cardiomyopathies (65;67) . A recent study measured mouse ECG as a function of time postinfection using two strains of T. cruzi to infect (68) . The data indicated that ~60% of infected mice (compared to ~5% of control) showed some conduction abnormality.
Could the reduced cardiomyocyte sialylation of chagasic patients lead to altered cardiac ion channel behavior and ultimately to the arrhythmias and heart failure observed in these patients? K v 4.2 and K v 4.3 are responsible for producing a rapidly activating and inactivating cardiac current, I to , involved in early action potential repolarization (phase 1).
A previous report indicated that changes in murine ventricular I to following neuraminidase treatment used to remove sialic acids may contribute to the extended AP duration and the increase in number of early after depolarizations (EAD) observed (21) . Our recent work showed that regulated changes in channel sialylation were sufficient to modulate action potential waveform, including duration (32) . Increased action potential duration would be predicted if K v channel activity were limited by reduced sialylation. With a rightward shift in the G-V relationship and no shift in the inactivationvoltage relationship, the window current, defined as the portion under the overlapping steady-state activation and inactivation curves, would be rightshifted and smaller. This would lead to an overall reduction in voltage-dependent K + current. Furthermore, K v 2.1, which produces a slowly inactivating current, aids in regulating excitability in cortical and hippocampal pyramidal neurons by acting as a suppressor during periods of hyperexcitability (69;70) . Reductions in K v 2.1 sialylation may limit K v 2.1 activity, disrupt this suppressive role, and thereby increase the frequency and/or duration of hyperexcitability in these neurons. Summary Here, the data show that reduced sialic acid levels attached to channel O-glycans cause unique depolarizing shifts in activation voltage for three K v channel isoforms that are not N-glycosylated. An electrostatic mechanism is apparently responsible for these effects, with O-linked sialic acids contributing to the external negative surface potential. Steady-state inactivation and recovery from fast inactivation were not impacted significantly by reduced sialylation; this would lead to further reductions in K v channel activity, likely extending the action potential. Mechanistically, this suggests an inhomogeneous influence of K v channel sialic acids on the electric field sensed by the activation, inactivation, and recovery gating mechanisms. Together, the data indicate that channel sialic acids attached to Oglycans modulate gating of K v channels that are not N-glycosylated and this modulation is unique for each isoform. This is the first study to report direct effects of O-glycans on voltage-gated ion channel gating, suggesting that sialylated K v channel O-glycans enhance channel activity. Such modulation is relevant to changes in action potential repolarization that occur as ion channel expression, distribution, and O-glycosylation are regulated. Table 2 for mean M r shifts ± SEM for 4-8 blots/isoform. 
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